Your browser doesn't support javascript.
loading
Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report.
Zuo, Wei; Wen, Li-Ping; Li, Jun; Mei, Dan; Fu, Qiang; Zhang, Bo.
Afiliación
  • Zuo W; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing.
  • Wen LP; Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education", Yantai University, Yantai, China.
  • Li J; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing.
  • Mei D; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing.
  • Fu Q; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing.
  • Zhang B; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing.
Medicine (Baltimore) ; 98(19): e15553, 2019 May.
Article en En | MEDLINE | ID: mdl-31083216
RATIONALE: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are 2 rare but life-threatening diseases characterized by detachment of epidermis, bullous skin lesions, and mucous membrane erosions. Drugs are highly suspected to be the causative agents. We report a case of SJS/TEN induced by oseltamivir, which is a very rare event. PATIENT CONCERNS: A 9-year-old girl with upper respiratory tract infections presented with generalized maculopapular rash the second day after taking oseltamivir. DIAGNOSIS: The diagnosis of SJS/TEN was made based on cytotoxic skin lesions and mucous membrane involvement. INTERVENTIONS: After discontinuing of the drug and combination therapy of corticosteroid and human immunoglobulin initiation, the lesions were improved. Human leukocyte antigen (HLA) gene sequencing was done. OUTCOMES: The girl was followed-up for 1 year. The skin and mucous membranes symptoms were relieved. LESSONS: We report this case to attract attention to the rare but serious side effect of this antiviral drug.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Síndrome de Stevens-Johnson / Oseltamivir Tipo de estudio: Diagnostic_studies Límite: Child / Female / Humans Idioma: En Revista: Medicine (Baltimore) Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Síndrome de Stevens-Johnson / Oseltamivir Tipo de estudio: Diagnostic_studies Límite: Child / Female / Humans Idioma: En Revista: Medicine (Baltimore) Año: 2019 Tipo del documento: Article